Is SGRY stock a Buy, Sell, or Hold?

Based on our analysis, SGRY is currently a HOLD with moderate confidence. 📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of SGRY stock?

Our analysis estimates the fair value range for SGRY to be between $15.14 and $16.05. The current price is $14.86.

What is the analyst price target for SGRY?

The average Wall Street analyst price target for SGRY is $25.45. This implies a potential upside of 75.8% from current levels.

SGRY Stock Analysis: Buy, Sell, or Hold?

SGRY - Surgery Partners, Inc. Common Stock

SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC

$14.86

0.38 (2.62%) ▲

HOLD

MODERATE Confidence

Protect Your SGRY Gains

Last Updated: January 30, 2026

Earnings: Mar 02, 2026 29d

Get Alerted When SGRY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: SGRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 8.1%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$21.32

Based on 6.1% avg growth

INTRINSIC VALUE TODAY

$13.24

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.1x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: SGRY is currently trading at $14.86, which is considered oversold relative to its 30-day fair value range of $15.14 to $16.05. The stock's valuation (Forward PE: 21.0) is in line with its historical norms (23.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, SGRY is in a strong downtrend. Immediate support is located at $14.35, while resistance sits at $16.44.

Market Sentiment: SGRY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.45 (+75.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $15.14 - $16.05

Company Quality Score 35/100 (SELL)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding SGRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 75.8% below Wall St target ($25.45)
CAUTION: 5-day price weakness (-7.9%) - monitor closely

Fair Price Analysis

30-Day Fair Range $15.14 - $16.05

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $14.35

Resistance Level $16.44

Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 21.04

Wall Street Target $25.45 (+75.8%)

Revenue Growth (YoY) 6.6%

Profit Margin -5.2%

Valuation Discount vs History -3.1% cheaper

PE vs Historical 21.0 vs 23.1 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -3.1% (market-implied from PE analysis)

1-Year Target $14.03 (-3%)

2-Year Target $13.60 (-6%)

3-Year Target $13.17 (-9%)

3-Yr Target (if PE normalizes) (PE: 21→23) $14.47 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.3, Growth: 8.1%) $19.40 (+34%)

Base: (SPY PE: 21.0, Growth: 8.1%) $18.30 (+26%)

Bear: (PE: 17.9, Growth: 8.1%) $15.56 (+7%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 21.0 to 23.1

Stabilization Target: $15.90 (+9.8%)

PE Expansion Potential: +9.8%

Last updated: January 31, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is SGRY showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Harrison R Bane SELL 9339 shares 2025-09-04

Teresa Deluca SELL 20018 shares 2025-08-11

View Insider Activity Scanner

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
HCA HCA Holdings Inc	BUY 25 analysts	$489	63 BUY
THC Tenet Healthcare Corpora…	STRONG BUY 22 analysts	$238	54 HOLD
EHC Encompass Health Corp	STRONG BUY 12 analysts	$140	54 HOLD
CMPS Compass Pathways Plc	STRONG BUY 11 analysts	$17	52 HOLD
CON Concentra Group Holdings…	STRONG BUY 8 analysts	$28	62 BUY

HCA HCA Holdings Inc

63 BUY

THC Tenet Healthcare …

54 HOLD

EHC Encompass Health …

54 HOLD

CMPS Compass Pathways …

52 HOLD

CON Concentra Group H…

62 BUY

Advanced SGRY Option Strategies

Professional options setups generated by AI based on today's SGRY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SGRY

SGRY Technical Chart SGRY Price Prediction SGRY Earnings Date SGRY Investment Advisor SGRY Fair Price Analyzer SGRY Options Advisor SGRY Options Chain SGRY Options Analysis SGRY Competitors

Compare SGRY with Other Stocks

Create New Comparison

Tradestie